Impact of Bronchopulmonary Dysplasia, Brain Injury, and Severe Retinopathy on the Outcome of Extremely Low-Birth-Weight Infants at 18 Months: Results from the Trial of Indomethacin Prophylaxis in Preterms

JAMA

Volumn 289, Issue 9, 2003, Pages 1124-1129

  Schmidt, Barbara ^a   Asztalos, Elizabeth V ^b   Roberts, Robin S ^a   Robertson, Charlene M T ^c   Sauve, Reginald S ^d   Whitfield, Michael F ^e  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c GLENROSE REHABILITATION HOSPITAL   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; BLINDNESS; BRAIN INJURY; CEREBRAL PALSY; CHILD DEATH; COGNITIVE DEFECT; ECHOGRAPHY; FEMALE; HEARING LOSS; HUMAN; INFANT; LONG TERM CARE; LOW BIRTH WEIGHT; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; NEWBORN MORBIDITY; OUTCOMES RESEARCH; PREMATURITY; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; RETINOPATHY; SENSORY DYSFUNCTION; BRAIN DISEASE; CLINICAL TRIAL; GESTATIONAL AGE; MORBIDITY; MULTICENTER STUDY; NEWBORN; PATHOPHYSIOLOGY; RETROLENTAL FIBROPLASIA; SOCIOECONOMICS; STATISTICAL MODEL; SURVIVAL; VERY LOW BIRTH WEIGHT;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLINDNESS; BRAIN DISEASES; BRONCHOPULMONARY DYSPLASIA; CEREBRAL PALSY; COGNITION DISORDERS; FEMALE; GESTATIONAL AGE; HEARING LOSS; HUMANS; INDOMETHACIN; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; LOGISTIC MODELS; MALE; MORBIDITY; PROGNOSIS; RETINOPATHY OF PREMATURITY; SOCIOECONOMIC FACTORS; SURVIVAL ANALYSIS;

EID: 0037420266     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.289.9.1124     Document Type: Article

References (22)

1. Singer L, Yamashita T, Lilien L, Collin M, Baley J. A longitudinal study of developmental outcome of infants with bronchopulmonary dysplasia and very low birth weight. Pediatrics. 1997;100:987-993.
2. Vohr BR, Wright LL, Dusick AM, et al. Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994. Pediatrics. 2000;105:1216-1226.
3. Hack M, Wilson-Costello D, Friedman H, Taylor GH, Schluchter M, Fanaroff AA. Neurodevelopment and predictors of outcomes of children with birth weights of less than 1000 g:1992-1995. Arch Pediatr Adolesc Med. 2000;154:725-731.
4. Palta M, Sadek-Badawi M, Evans M, Weinstein MR, McGuinness G, for the Newborn Lung Project. Functional assessment of a multicenter very low-birth-weight cohort at age 5 years. Arch Pediatr Adolesc Med. 2000;154:23-30.
5. Aziz K, Vickar DB, Sauve RS, Etches PC, Pain KS, Robertson CM. Province-based study of neurologic disability of children weighing 500 through 1249 grams at birth in relation to neonatal cerebral ultrasound findings. Pediatrics. 1995;95:837-844.
6. Pinto-Martin JA, Riolo S, Cnaan A, Holzman C, Susser MW, Paneth N. Cranial ultrasound prediction of disabling and nondisabling cerebral palsy at age two in a low birth weight population. Pediatrics. 1995;95:249-254.
7. Waugh J, O'Callaghan MJ, Tudehope DI, et al. Prevalence and aetiology of neurological impairment in extremely low birthweight infants. J Paediatr Child Health. 1996;32:120-124.
8. O'Connor AR, Stephenson T, Johnson A, et al. Long-term ophthalmic outcome of low birth weight children with and without retinopathy of prematurity. Pediatrics. 2002;109:12-18.
9. Msall ME, Phelps DL, DiGaudio KM, et al. Severity of neonatal retinopathy of prematurity is predictire of neurodevelopmental functional outcome at age 5.5 years. Pediatrics. 2000;106:998-1005.
10. Schmidt B, Davis P, Moddemann D, et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med. 2001;344:1966-1972.
11. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics. 1988;82:527-532.
12. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr. 1978;92:529-534.
13. An international classification of retnopathy of prematurity. Pediatrics. 1984;74:127-133.
14. International Committee for the Classification of the Late Stages of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. II: the classification of retinal detachment. Arch Ophthalmol. 1987;105:906-912.
15. Bayley N. Bayley Scales of Infant Development: Manual. 2nd ed. San Antonio, Tex: The Psychological Corp, Harcourt Brace & Co; 1993.
16. Hosmer DW, Lemeshow S. Applied Logistic Regression, 2nd ed, New York, NY: John Wiley; 2000:1-30.
17. Finnstrom O, Otterblad Olausson P, Sedin G, et al. Neurosensory outcome and growth at three years in extremely low birthweight infants: follow-up results from the Swedish national prospective study. Acta Paediatr. 1998;87:1055-1060.
18. Davis PG, Thorpe K, Roberts R, Schmidt B, Doyle LW, Kirpalani H, and the Trial of Indomethacin Prophylaxis in Preterms (TIPP) Investigators. Evaluating "old" definitions for the "new" bronchopulmonary dysplasia. J Pediatr. 2002;140:555-560.
19. Doyle LW, for the Victorian Infant Collaborative Study Group. Outcome at 5 years of age of children 23 to 27 weeks' gestation: refining the prognosis. Pediatrics. 2001;108:134-141.
20. Victorian Infant Collaborative Study Group. Improved outcome into the 1990s for infants weighing 500-999 g at birth. Arch Dis Child Fetal Neonatal Ed. 1997;77:F91-F94.
21. Butler C, Chambers H, Goldstein M, et al. Evaluating research in developmental disabilities: a conceptual framework for reviewing treatment outcomes. Dev Med Child Neurol. 1999;41:55-59.
22. Wood NS, Marlow N, Costeloe K, Gibson AT, Wilkinson AR, for the EPICure Study Group. Neurologic and developmental disability after extremely preterm birth. N Engl J Med. 2000;343:378-384.